These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Suppression of lordosis behavior by the putative 5-HT receptor agonist 8-OH-DPAT in the rat. Ahlenius S; Fernandez-Guasti A; Hjorth S; Larsson K Eur J Pharmacol; 1986 May; 124(3):361-3. PubMed ID: 2942412 [TBL] [Abstract][Full Text] [Related]
44. Synergistic enhancement of the acoustic startle reflex by dopamine D1 and 5-HT1A agonists and corresponding changes in c-Fos expression in the dorsal raphe of rats. Meloni EG; Davis M Psychopharmacology (Berl); 2000 Sep; 151(4):359-67. PubMed ID: 11026743 [TBL] [Abstract][Full Text] [Related]
45. Influence of route of administration on potency of the selective 5HT-1A agonist, 8-hydroxy-2-(di-n-propylamino)tetralin, in rats. Fuller RW; Snoddy HD Res Commun Chem Pathol Pharmacol; 1987 Dec; 58(3):409-12. PubMed ID: 2449711 [TBL] [Abstract][Full Text] [Related]
46. Discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OHDPAT): implications for understanding the actions of novel anxiolytics. Cunningham KA; Callahan PM; Appel JB Eur J Pharmacol; 1987 Jun; 138(1):29-36. PubMed ID: 2887435 [TBL] [Abstract][Full Text] [Related]
47. Mechanisms of serotonin receptor agonist-induced activation of the hypothalamic-pituitary-adrenal axis in the rat. Calogero AE; Bagdy G; Szemeredi K; Tartaglia ME; Gold PW; Chrousos GP Endocrinology; 1990 Apr; 126(4):1888-94. PubMed ID: 2156670 [TBL] [Abstract][Full Text] [Related]
48. Central dopaminergic and 5-hydroxytryptaminergic effects of C3-methylated derivatives of 8-hydroxy-2-(di-n-propylamino)tetralin. Mellin C; Björk L; Karlén A; Johansson AM; Sundell S; Kenne L; Nelson DL; Andén NE; Hacksell U J Med Chem; 1988 Jun; 31(6):1130-40. PubMed ID: 2967376 [TBL] [Abstract][Full Text] [Related]
49. Release of endogenous aspartate from rat cerebellum slices and synaptosomes: inhibition mediated by a 5-HT2 receptor and by a 5-HT1 receptor of a possibly novel subtype. Maura G; Barzizza A; Folghera S; Raiteri M Naunyn Schmiedebergs Arch Pharmacol; 1991 Mar; 343(3):229-36. PubMed ID: 1830929 [TBL] [Abstract][Full Text] [Related]
50. The behavioural, but not the hypothermic or corticosterone, response to 8-hydroxy-2-(DI-n-propylamino)-tetralin, is antagonized by NAN-190 in the rat. Przegaliński E; Ismaiel AM; Chojnacka-Wójcik E; Budziszewska B; Tatarczyńska E; Błaszczyńska E Neuropharmacology; 1990 Jun; 29(6):521-6. PubMed ID: 2143565 [TBL] [Abstract][Full Text] [Related]
51. Discriminative stimulus properties of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH DPAT). Glennon RA Pharmacol Biochem Behav; 1986 Jul; 25(1):135-9. PubMed ID: 2944129 [TBL] [Abstract][Full Text] [Related]
52. Hyperinsulinemia of the genetically obese (fa/fa) rat is decreased by a low dose of the 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). Chaouloff F; Jeanrenaud B Eur J Pharmacol; 1988 Feb; 147(1):111-8. PubMed ID: 2967189 [TBL] [Abstract][Full Text] [Related]
53. The long-term effects of 8-hydroxy-2-(di-n-propyl-amino)tetralin (8-OH-DPAT) on copulatory and exploratory behaviour in male rats. Johansson CE; Meyerson BJ; Höglund AU Eur J Pharmacol; 1990 Mar; 178(1):1-9. PubMed ID: 2139613 [TBL] [Abstract][Full Text] [Related]
54. Cardiovascular effects in the Sprague-Dawley rat of 8-hydroxy-2(di-N-propylamino) tetralin, a selective 5-hydroxytryptamine receptor agonist. Gradin K; Pettersson A; Hjorth S; Hedner T; Arvidsson LE; Persson B J Pharm Pharmacol; 1985 Apr; 37(4):263-5. PubMed ID: 2860226 [TBL] [Abstract][Full Text] [Related]
55. Low doses of the putative serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) elicit feeding in the rat. Dourish CT; Hutson PH; Curzon G Psychopharmacology (Berl); 1985; 86(1-2):197-204. PubMed ID: 3161115 [TBL] [Abstract][Full Text] [Related]
56. 8-Hydroxy-2-(di-n-propylamino) tetralin, a selective serotonin1A receptor agonist, blocks haloperidol-induced catalepsy by an action on raphe nuclei medianus and dorsalis. Invernizzi RW; Cervo L; Samanin R Neuropharmacology; 1988 May; 27(5):515-8. PubMed ID: 2969083 [TBL] [Abstract][Full Text] [Related]
57. Effects of the C3-methylated derivatives of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on central 5-hydroxytryptamine receptors. Björk L; Mellin C; Hacksell U; Andén NE Eur J Pharmacol; 1987 Nov; 143(1):55-63. PubMed ID: 2961582 [TBL] [Abstract][Full Text] [Related]
58. The pharmacology of the behavioural and hypothermic responses of rats to 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). Goodwin GM; De Souza RJ; Green AR; Heal DJ Psychopharmacology (Berl); 1987; 91(4):506-11. PubMed ID: 2954179 [TBL] [Abstract][Full Text] [Related]
59. Different effects on the responses of functional pre- and postsynaptic 5-HT1A receptors by repeated treatment of rats with the 5-HT1A receptor agonist 8-OH-DPAT. Larsson LG; Rényi L; Ross SB; Svensson B; Angeby-Möller K Neuropharmacology; 1990 Feb; 29(2):85-91. PubMed ID: 1691832 [TBL] [Abstract][Full Text] [Related]
60. The role of putative 5-HT1A and 5-HT1B receptors in the control of feeding in rats. Bendotti C; Samanin R Life Sci; 1987 Aug; 41(5):635-42. PubMed ID: 2955189 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]